0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-11-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14429629 2023-11-01 2024-10-31 14429629 2024-10-31 14429629 2023-10-31 14429629 2022-11-01 2023-10-31 14429629 2023-10-31 14429629 2022-10-31 14429629 bus:Director1 2023-11-01 2024-10-31 14429629 core:WithinOneYear 2024-10-31 14429629 core:WithinOneYear 2023-10-31 14429629 core:AfterOneYear 2024-10-31 14429629 core:AfterOneYear 2023-10-31 14429629 bus:Micro-entities 2023-11-01 2024-10-31 14429629 bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 14429629 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 14429629 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 14429629 bus:FullAccounts 2023-11-01 2024-10-31
COMPANY REGISTRATION NUMBER: 14429629
Bayesian Technologies Limited
Filleted Unaudited Financial Statements
31 October 2024
Bayesian Technologies Limited
Statement of Financial Position
31 October 2024
2024
2023
£
£
£
Current assets
258,815
234,960
Prepayments and accrued income
125,000
---------
---------
258,815
359,960
Creditors: amounts falling due within one year
340
94,640
---------
---------
Net current assets
258,475
265,320
---------
---------
Total assets less current liabilities
258,475
265,320
Creditors: amounts falling due after more than one year
269,298
269,298
---------
---------
(10,823)
(3,978)
---------
---------
Capital and reserves
( 10,823)
( 3,978)
--------
-------
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 11 March 2025 , and are signed on behalf of the board by:
Charlotte Golunski
Director
Company registration number: 14429629
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is St John's Innovation Centre, Cowley Road, Cambridge, CB4 0WS, United Kingdom.